PIERER Mobility AG

  • WKN: A2JKHY
  • ISIN: AT0000KTMI02
  • Land: Österreich

Nachricht vom 22.10.2021 | 17:43

PIERER Mobility AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

PIERER Mobility AG
22.10.2021 / 17:43
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Vienna, 22 October 2021 - Release according to Article 40, Section 1 WpHG

PIERER Mobility AG: Release according to Article 40, Section 1 WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018

1. Issuer

PIERER Mobility AG, Edisonstraße 1, 4600 Wels, Austria

2. Reason for the notification

Acquisition or disposal of voting rights, Change in the total number of voting rights

3. Person subject to notification obligation

Name: Stefan Pierer

4. Name of shareholder(s): (if not the same as stated under point 3)

Pierer Konzerngesellschaft mbH, Pierer Bajaj AG (formely PTW Holding AG)

5. Date on which the threshold was crossed or reached

22.10.2021

6. Total positions

  % of voting rights attached to shares (7.A) % of voting rights through financial/other instruments (7.B.1 + 7.B.2)

Total of both in % (7.A + 7.B)


Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached 75,64 % 0,00 % 75,64 % 33 796 535
Position of previous notification (if applicable) 63,37 % 0,00 % 63,37 %  
 

 

7. Details - Notified details of the resulting situation

A: Voting rights attached to shares

ISIN Code
Number of voting rights % of voting rights
Direct
(Sec 130 BörseG 2018)
Indirect
(Sec 133 BörseG 2018)
Direct
(Sec 130 BörseG 2018)
Indirect
(Sec 133 BörseG
2018)
AT0000KTMI02 0 25 564 884 0,00 % 75,64 %
SUBTOTAL A 25 564 884 75,64 %
 
B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

Type of instrument

Expiration Date

Exercise Period
Number of voting
rights that may be
acquired if the
instrument is exercised

% of voting rights
         
    SUBTOTAL B.1    
 
B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018
Type of instrument Expiration Date Exercise Period Physical /
Cash Settlement
Number of
voting rights
% of voting rights
           
      SUBTOTAL B.2    
 

 

8. Information in relation to the person subject to the notification obligation

[Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.]

X Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

No. Name Directly controlled by No. Shares held directly (%) Financial/other
instruments held directly (%)
Total of both (%)
1 Stefan Pierer   0,00 % 0,00 % 0,00 %
2 Pierer Konzerngesellschaft mbH 1 2,32 % 0,00 % 2,32 %
3 Pierer Industrie AG 2 0,00 % 0,00 % 0,00 %
4 Pierer Bajaj AG (formely PTW Holding AG 3 73,32 % 0,00 % 73,32 %
 

 

9. In case of proxy voting

Date of general meeting: na

10. Other remarks

On 22 October 2021, the implementation of a capital increase against contribution in kind from the existing authorised capital was registered. The share capital was increased from EUR 22,538,674 by EUR 11,257,861 to EUR 33,796,535.

Submitted by: PIERER Mobility AG
Edisonstraße 1, 4600 Wels
Österreich

Contract person: Mag. Michaela Friepeß
Tel.: +43 (0)7242 / 69402
E-Mail: ir@pierermobility.com
Website: https://www.pierermobility.com/
ISIN(s): AT0000KTMI02

 



22.10.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Neufassung der Dividendenpolitik der Allianz SE

02. Dezember 2021, 20:33

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021